These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 24763262)

  • 1. 4-Oxo-1,4-dihydro-quinoline-3-carboxamides as BACE-1 inhibitors: synthesis, biological evaluation and docking studies.
    Liu P; Niu Y; Wang C; Sun Q; Zhai Y; Yu J; Sun J; Xu F; Yan G; Huang W; Liang L; Xu P
    Eur J Med Chem; 2014 May; 79():413-21. PubMed ID: 24763262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 2-Substituted-thio-N-(4-substituted-thiazol/1H-imidazol-2-yl)acetamides as BACE1 inhibitors: Synthesis, biological evaluation and docking studies.
    Yan G; Hao L; Niu Y; Huang W; Wang W; Xu F; Liang L; Wang C; Jin H; Xu P
    Eur J Med Chem; 2017 Sep; 137():462-475. PubMed ID: 28624701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rational design, synthesis and in vitro evaluation of allylidene hydrazinecarboximidamide derivatives as BACE-1 inhibitors.
    Jain P; Wadhwa PK; Rohilla S; Jadhav HR
    Bioorg Med Chem Lett; 2016 Jan; 26(1):33-7. PubMed ID: 26614409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and synthesis of 1,4-dihydropyridine derivatives as BACE-1 inhibitors.
    Choi SJ; Cho JH; Im I; Lee SD; Jang JY; Oh YM; Jung YK; Jeon ES; Kim YC
    Eur J Med Chem; 2010 Jun; 45(6):2578-90. PubMed ID: 20303626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis and biological evaluation of tasiamide B derivatives as BACE1 inhibitors.
    Liu J; Chen W; Xu Y; Ren S; Zhang W; Li Y
    Bioorg Med Chem; 2015 May; 23(9):1963-74. PubMed ID: 25842365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A stereoselective approach to peptidomimetic BACE1 inhibitors.
    Butini S; Gabellieri E; Brindisi M; Giovani S; Maramai S; Kshirsagar G; Guarino E; Brogi S; La Pietra V; Giustiniano M; Marinelli L; Novellino E; Campiani G; Cappelli A; Gemma S
    Eur J Med Chem; 2013; 70():233-47. PubMed ID: 24158015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-based design of novel dihydroisoquinoline BACE-1 inhibitors that do not engage the catalytic aspartates.
    Bowers S; Xu YZ; Yuan S; Probst GD; Hom RK; Chan W; Konradi AW; Sham HL; Zhu YL; Beroza P; Pan H; Brecht E; Yao N; Lougheed J; Tam D; Ren Z; Ruslim L; Bova MP; Artis DR
    Bioorg Med Chem Lett; 2013 Apr; 23(7):2181-6. PubMed ID: 23465612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, in vitro biological evaluation and molecular docking studies of benzimidamides as potential BACE1 inhibitors.
    Niu Y; Gao H; Xu F; Wang C; Liu P; Yang G; Sun Q; Xu P
    Chem Biol Drug Des; 2012 Nov; 80(5):775-80. PubMed ID: 22882897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and synthesis of novel 3,5-bis-N-(aryl/heteroaryl) carbamoyl-4-aryl-1,4-dihydropyridines as small molecule BACE-1 inhibitors.
    Razzaghi-Asl N; Firuzi O; Hemmateenejad B; Javidnia K; Edraki N; Miri R
    Bioorg Med Chem; 2013 Nov; 21(22):6893-909. PubMed ID: 24113238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alzheimer's disease: identification and development of β-secretase (BACE-1) binding fragments and inhibitors by dynamic ligation screening (DLS).
    Fernández-Bachiller MI; Horatscheck A; Lisurek M; Rademann J
    ChemMedChem; 2013 Jul; 8(7):1041-56. PubMed ID: 23757181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis and in vitro evaluation studies of sulfonyl-amino-acetamides as small molecule BACE-1 inhibitors.
    Jain P; Wadhwa PK; Gunapati S; Jadhav HR
    Bioorg Med Chem; 2016 Jun; 24(11):2567-2575. PubMed ID: 27102162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of pharmacophore model, synthesis and biological evaluation of N-phenyl-1-arylamide and N-phenylbenzenesulfonamide derivatives as BACE 1 inhibitors.
    Huang W; Yu H; Sheng R; Li J; Hu Y
    Bioorg Med Chem; 2008 Dec; 16(24):10190-7. PubMed ID: 19013073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 3,3-Difluoro-3,4,5,6-tetrahydropyridin-2-amines: Potent and permeable BACE-1 inhibitors.
    Peschiulli A; Oehlrich D; Rombouts F; Vos A; Gijsen HJ
    Bioorg Med Chem Lett; 2020 Apr; 30(8):126999. PubMed ID: 32089426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and synthesis of hydroxyethylamine (HEA) BACE-1 inhibitors: structure-activity relationship of the aryl region.
    Probst GD; Bowers S; Sealy JM; Stupi B; Dressen D; Jagodzinska BM; Aquino J; Gailunas A; Truong AP; Tso L; Xu YZ; Hom RK; John V; Tung JS; Pleiss MA; Tucker JA; Konradi AW; Sham HL; Jagodzinski J; Toth G; Brecht E; Yao N; Pan H; Lin M; Artis DR; Ruslim L; Bova MP; Sinha S; Yednock TA; Gauby S; Zmolek W; Quinn KP; Sauer JM
    Bioorg Med Chem Lett; 2010 Oct; 20(20):6034-9. PubMed ID: 20822903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biological and computational evaluation of resveratrol inhibitors against Alzheimer's disease.
    Koukoulitsa C; Villalonga-Barber C; Csonka R; Alexi X; Leonis G; Dellis D; Hamelink E; Belda O; Steele BR; Micha-Screttas M; Alexis MN; Papadopoulos MG; Mavromoustakos T
    J Enzyme Inhib Med Chem; 2016; 31(1):67-77. PubMed ID: 26147348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multipotent AChE and BACE-1 inhibitors for the treatment of Alzheimer's disease: Design, synthesis and bio-analysis of 7-amino-1,4-dihydro-2H-isoquilin-3-one derivates.
    Zhao XJ; Gong DM; Jiang YR; Guo D; Zhu Y; Deng YC
    Eur J Med Chem; 2017 Sep; 138():738-747. PubMed ID: 28728106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diastereoselective synthesis of fused cyclopropyl-3-amino-2,4-oxazine β-amyloid cleaving enzyme (BACE) inhibitors and their biological evaluation.
    Low JD; Bartberger MD; Cheng Y; Whittington D; Xue Q; Wood S; Allen JR; Minatti AE
    Bioorg Med Chem Lett; 2018 Apr; 28(6):1111-1115. PubMed ID: 29426770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and synthesis of donepezil analogues as dual AChE and BACE-1 inhibitors.
    Gabr MT; Abdel-Raziq MS
    Bioorg Chem; 2018 Oct; 80():245-252. PubMed ID: 29966870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Searching for the Multi-Target-Directed Ligands against Alzheimer's disease: discovery of quinoxaline-based hybrid compounds with AChE, H₃R and BACE 1 inhibitory activities.
    Huang W; Tang L; Shi Y; Huang S; Xu L; Sheng R; Wu P; Li J; Zhou N; Hu Y
    Bioorg Med Chem; 2011 Dec; 19(23):7158-67. PubMed ID: 22019465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study on the active mechanism of β-secretase inhibitors by molecular simulations.
    Tian YL; Lv M; Li JJ; Xu T; Zhai HL; Zhang XY
    Eur J Pharm Sci; 2015 Aug; 76():138-48. PubMed ID: 25965961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.